Cargando…
A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide Inhibitor
[Image: see text] Noroviruses are the major cause of human epidemic nonbacterial gastroenteritis. Viral replication requires a 3C cysteine protease that cleaves a 200 kDa viral polyprotein into its constituent functional proteins. Here we describe the X-ray structure of the Southampton norovirus 3C...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2010
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058531/ https://www.ncbi.nlm.nih.gov/pubmed/21128685 http://dx.doi.org/10.1021/bi1008497 |
_version_ | 1782200370738495488 |
---|---|
author | Hussey, Robert J. Coates, Leighton Gill, Raj S. Erskine, Peter T. Coker, Shu-Fen Mitchell, Ed Cooper, Jonathan B. Wood, Steve Broadbridge, Robert Clarke, Ian N. Lambden, Paul R. Shoolingin-Jordan, Peter M. |
author_facet | Hussey, Robert J. Coates, Leighton Gill, Raj S. Erskine, Peter T. Coker, Shu-Fen Mitchell, Ed Cooper, Jonathan B. Wood, Steve Broadbridge, Robert Clarke, Ian N. Lambden, Paul R. Shoolingin-Jordan, Peter M. |
author_sort | Hussey, Robert J. |
collection | PubMed |
description | [Image: see text] Noroviruses are the major cause of human epidemic nonbacterial gastroenteritis. Viral replication requires a 3C cysteine protease that cleaves a 200 kDa viral polyprotein into its constituent functional proteins. Here we describe the X-ray structure of the Southampton norovirus 3C protease (SV3CP) bound to an active site-directed peptide inhibitor (MAPI) which has been refined at 1.7 Å resolution. The inhibitor, acetyl-Glu-Phe-Gln-Leu-Gln-X, which is based on the most rapidly cleaved recognition sequence in the 200 kDa polyprotein substrate, reacts covalently through its propenyl ethyl ester group (X) with the active site nucleophile, Cys 139. The structure permits, for the first time, the identification of substrate recognition and binding groups in a noroviral 3C protease and thus provides important new information for the development of antiviral prophylactics. |
format | Text |
id | pubmed-3058531 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-30585312011-03-16 A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide Inhibitor Hussey, Robert J. Coates, Leighton Gill, Raj S. Erskine, Peter T. Coker, Shu-Fen Mitchell, Ed Cooper, Jonathan B. Wood, Steve Broadbridge, Robert Clarke, Ian N. Lambden, Paul R. Shoolingin-Jordan, Peter M. Biochemistry [Image: see text] Noroviruses are the major cause of human epidemic nonbacterial gastroenteritis. Viral replication requires a 3C cysteine protease that cleaves a 200 kDa viral polyprotein into its constituent functional proteins. Here we describe the X-ray structure of the Southampton norovirus 3C protease (SV3CP) bound to an active site-directed peptide inhibitor (MAPI) which has been refined at 1.7 Å resolution. The inhibitor, acetyl-Glu-Phe-Gln-Leu-Gln-X, which is based on the most rapidly cleaved recognition sequence in the 200 kDa polyprotein substrate, reacts covalently through its propenyl ethyl ester group (X) with the active site nucleophile, Cys 139. The structure permits, for the first time, the identification of substrate recognition and binding groups in a noroviral 3C protease and thus provides important new information for the development of antiviral prophylactics. American Chemical Society 2010-12-03 2011-01-18 /pmc/articles/PMC3058531/ /pubmed/21128685 http://dx.doi.org/10.1021/bi1008497 Text en Copyright © 2010 American Chemical Society http://pubs.acs.org This is an open-access article distributed under the ACS AuthorChoice Terms & Conditions. Any use of this article, must conform to the terms of that license which are available at http://pubs.acs.org. |
spellingShingle | Hussey, Robert J. Coates, Leighton Gill, Raj S. Erskine, Peter T. Coker, Shu-Fen Mitchell, Ed Cooper, Jonathan B. Wood, Steve Broadbridge, Robert Clarke, Ian N. Lambden, Paul R. Shoolingin-Jordan, Peter M. A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide Inhibitor |
title | A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide Inhibitor |
title_full | A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide Inhibitor |
title_fullStr | A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide Inhibitor |
title_full_unstemmed | A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide Inhibitor |
title_short | A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide Inhibitor |
title_sort | structural study of norovirus 3c protease specificity: binding of a designed active site-directed peptide inhibitor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058531/ https://www.ncbi.nlm.nih.gov/pubmed/21128685 http://dx.doi.org/10.1021/bi1008497 |
work_keys_str_mv | AT husseyrobertj astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT coatesleighton astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT gillrajs astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT erskinepetert astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT cokershufen astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT mitchelled astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT cooperjonathanb astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT woodsteve astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT broadbridgerobert astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT clarkeiann astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT lambdenpaulr astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT shoolinginjordanpeterm astructuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT husseyrobertj structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT coatesleighton structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT gillrajs structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT erskinepetert structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT cokershufen structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT mitchelled structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT cooperjonathanb structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT woodsteve structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT broadbridgerobert structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT clarkeiann structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT lambdenpaulr structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor AT shoolinginjordanpeterm structuralstudyofnorovirus3cproteasespecificitybindingofadesignedactivesitedirectedpeptideinhibitor |